CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will present at the 26th Annual JPMorgan Healthcare Conference, being held January 7–10, 2008 at the Westin St. Francis Hotel in San Francisco, California. Harvey J. Berger, M.D., chairman and chief executive officer at ARIAD, will provide a company overview on Wednesday, January 9 at 11:30 a.m. (PT), highlighting the global clinical development plan for ARIAD’s lead product deforolimus, as well as top-line financial guidance for the Company’s fiscal year 2008.
